Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Paget's disease of bone Age: Adult |
Dose: Infusion – 5 mg Frequency: single infusion Duration: over 15 minutes Note: Patients should receive elemental Calcium 1,500 mg and vitamin D 800 IU daily particularly within 2 weeks after administration. |
|
Indication: Paget's disease of bone Age: Adult Condition: Patients who have relapsed |
Dose: Infusion – 5 mg Frequency: additional infusion Note: May be given after an interval of at least 1 year from the initial dose. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Safety and efficacy not established |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Creatinine Clearance greater than 35 mL/minute |
Dose: Dose: Note: No adjustment needed |
|
Condition: Creatinine Clearance less than 35 mL/minute |
Dose: Dose: Note: Contraindicated |
Administration
- Given as IV infusion
- Must be diluted before use
Side Effect
- Arthralgia
- fever
- flu-like symptoms
- myalgia
- headache
- pain in extremity
- nausea
- vomiting
- diarrhoea
- eye inflammation
- alopecia
- hyperhidrosis
- bone/joint/muscle pain
- osteonecrosis of the jaw
- femoral fracture
- hypersensitivity reactions (eg urticaria
- angioedema)
- Stevens-Johnson syndrome
- toxic epidermal necrolysis
- hypotension
- Severe hypocalcaemia
- severe kidney problems
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Aminoglycosides, loop diuretics (Furosemide, Bumetanide, Ethacrynic acid, Torsemide)
|
Increased risk of hypocalcaemia
|
|
Nephrotoxic agents
|
Increased risk renal dysfunction
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hypocalcaemia
|
Risk of calcium imbalance
|
|
Severe Renal Impairment
|
Risk of kidney damage
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.